title: Managing heart failure better: the value of implantable device data.
abstract: The heart failure disease state is challenging, time consuming and expensive to manage. Physicians are responsible for initiating, titrating and optimizing drug and device therapy to reduce morbidity and mortality. Failure to manage these aspects of care often results in worsening of symptoms and recurrent hospitalizations. This paper reviews the data implantable devices provide and how this data can assist in optimally managing the patient with heart failure.
authors.affiliation: Department of Internal Medicine, University of Missouri, USA. BestJ@health.missouri.edu
authors.forename: John F
authors.initials: JF
authors.lastname: Best
authors.forename: Helen
authors.initials: H
authors.lastname: Feldker
authors.forename: Kul
authors.initials: K
authors.lastname: Aggarwal
authors.forename: Lokesh
authors.initials: L
authors.lastname: Tejwani
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000368:Aged; D001281:Atrial Fibrillation / Q000628:therapy; D017147:Defibrillators, Implantable; D005260:Female; D006333:Heart Failure / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D010349:Patient Compliance; D014882:Water-Electrolyte Balance / Q000502:physiology
chemical_list: D000319:Adrenergic beta-Antagonists